Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a woman with total-body hair loss grow her hair back.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Raltegravir may cause hair loss in some patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

AP-1 controls tumor cell type by affecting key signaling pathways.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Erlotinib can cause nonscarring hair loss and itchy skin.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Cancer prevention has advanced significantly, with some strategies proving successful.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Ruxolitinib can help regrow hair in severe alopecia areata.

Activin B improves wound healing and hair growth by helping stem cells move using certain cell signals.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.